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ABSTRACT: The 2019-2020 SARS-related coronavirus-2 (SARS-CoV-2) pandemic has brought unprecedented 
challenges to healthcare sectors around the world. As of November 2020, there have been over 64 million confirmed 
cases and approaching 2 million deaths globally. Despite the large number of positive cases, there are very limited 
established standards of care and therapeutic options available. To date, there is still no Food and Drug 
Administration (FDA) approved vaccine for COVID-19, although there are several options in various clinical trial 
stages. Herein, we have performed a global review evaluating the roles of age and sex on COVID-19 hospitalizations, 
ICU admissions, deaths in hospitals, and deaths in nursing homes. We have identified a trend in which elderly and 
male patients are significantly affected by adverse outcomes. There is evidence suggesting that sex hormone levels 
can influence immune system function against SARS-CoV-2 infection, thus reducing the adverse effects of COVID-
19. Since older adults have lower levels of these sex hormones, we therefore speculate, within rational scientific 
context, that sex steroids, such as estrogen and progesterone, needs further consideration for use as alternative 
therapeutic option for treating COVID-19 elderly patients. To our knowledge, this is the first comprehensive article 
evaluating the significance of sex hormones in COVID-19 outcomes in older adults. 
 





Amidst the SARS-related coronavirus-2 (SARS-CoV-2) 
pandemic, it is important to investigate vulnerable 
populations and possible treatment options. Despite 
public health campaigns to encourage social distancing, 
quarantining, hygiene practices, and wearing face masks, 
the number of cases of Coronavirus Disease 2019 
(COVID-19) has yet to decline [1-3]. The virus was first 
identified in Wuhan, Hubei, People’s Republic of China 
in December 2019 when cases of unexplained pneumonia 
and acute respiratory distress syndrome (ARDS) were 
   Volume 12, Number 2; 671-683, April 2021                       
 Okpechi SC., et al                                                                                                  Global sex disparity of COVID-19 
Aging and Disease • Volume 12, Number 2, April 2021                                                                              672 
 
linked to an open-air seafood wholesale market. Scientists 
have proposed that the virus is transmitted to humans from 
the reservoir bats through different hosts [4].  By January 
2020, the virus was only spreading within Wuhan; but 
since then, near global spread has occurred resulting in the 
World Health Organization (WHO) declaring a 
‘pandemic’ on March 11th, 2020 [5]. 
The geriatric population is particularly vulnerable to 
suffering severe symptoms and mortality due to pre-
existing comorbidities and diminished immunity [6, 7]. 
New data have revealed that men are at greater risk of 
suffering severe symptoms and mortality compared to 
women. According to information gathered from Global 
Health 50/50.org, the populations more likely to suffer 
severe symptoms exist at the intersection of old age and 
being male. There is speculation that the effect of sex 
steroid hormones may modestly contribute to this 
disparity of increased intensive care unit (ICU) 
admissions between men and women. Additionally, the 
natural waning of hormone production over the course of 
one’s lifetime can similarly account for the increased risk 
of death in the elderly population [8]. The correlation 
between sex hormones, disease severity, and death rates 
reveals the potential of utilizing hormone replacement 
therapy (HRT) to modulate the immune response to 
increase resilience to adverse disease outcomes [9, 10]. 
Nursing homes are well-documented settings for 
acquisition of nosocomial infection. Transmission of the 
SARS-CoV-2 virus through droplets makes it difficult to 
properly quarantine patients residing in these healthcare 
facilities [11]. Because COVID-19 has proven to be fatal 
particularly in the elderly population, it is necessary to 
consider possible agents that can minimize the bodily 
inflammatory responses that may lead to death. As 
previously stated, men are more likely than women to 
develop severe symptoms. One advantage that women 
have is higher levels of estrogen and progesterone, which 
has been shown to modulate a more robust immune 
response [12-15]. In order to decrease the incidence of 
infection and disease severity of COVID-19, HRT may be 
proposed as a method of boosting immunity of individuals 
who are most at risk. HRT has been used to alleviate 
symptoms of menopause and aging in both men and 
women, respectively. Currently there are two clinical 
studies investigating the effectiveness of estrogen and 
progesterone therapy to decrease disease severity of 
COVID-19 (Table 1). Overall, we propose that the clinical 
application of sex hormone therapy might be a viable 
alternative for the treatment of the adverse inflammatory 
effects of COVID-19 in older adults, especially males, as 
they are the most affected of both sexes.  
 
Table 1. COVID-19 Clinical Trials Using Hormone Replacement Therapy (HRT). 
 
Clinical Trial Description Intervention Phase Status Eligibility 
Participant   
# 




 Clinical Trial 
Identifier:  
NCT04359329 
The use of an estrogen patch 
for 7 days could reduce the 
severity of COVID-19 
symptoms. Determined by 
the rate of hospitalization, 
transfer to ICU, intubation, 






2 Recruiting 18+ males, 55+ 
female, COVID-19+, 
1+ of the following 
symptoms; 
fever>100.5, SOB, 









Identifier:   
NCT04365127 
The administration of 
progesterone to determine 
the safety and efficacy in 
hospitalized COVID-19 
positive males. Determined 
by the clinical status of 
subject at Day 15 and Day 






for 5 days 








ray, ↓ O2saturation  
40 
 
2. SARS-CoV-2: Structure, mechanism of infection, 
and COVID-19 symptoms 
 
SARS-CoV-2 is an enveloped, positive sense, single 
stranded RNA virus that is ~30 kb in length [4]. It is a 
member of the genus Betacoronavirus and the subgenus 
Sarbecovirus. Its genome codes for 4 structural proteins, 
one of which is the Spike (S) glycoprotein. S proteins are 
responsible for attracting and facilitating binding with 
human Angiotensin Converting Enzyme 2 (ACE-2) 
receptors, found in human respiratory epithelium and lung 
parenchyma, thus aiding viral entry [4]. ACE-2 is a key 
component to vasodilation via the Renin-Angiotensin-
Aldosterone-System (RAAS) and is upregulated in 
commonly used pharmacotherapies for managing blood 
pressure. Because binding of the viral S protein to ACE-2 
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may increase the risk of infection, ACE inhibitors have 
been suggested as a possible therapy for COVID-19. 
Interestingly, it was recently reported that sex steroids can 
skew ACE-2 expression in human airway; therefore, it is 
plausible to believe that there is a relationship between the 
levels of endogenous sex hormones, ACE-2 expression, 
and the severity of SARS-CoV-2 infection. SARS-CoV-2 
is the 7th virus of the family Coronaviridae 
(Coronaviruses) known to infect humans; four of them 
being typical causes of the common cold [16]. The SARS-
CoV-2 virus is most similar to the Severe Acute 
Respiratory Syndrome Coronavirus (SARS-CoV), which 
caused the SARS pandemic from 2002-2003 [14].  
In a study analyzing the viral genomic sequences of 
SARS-CoV and SARS-CoV-2, scientists noted a 79% 
similarity on a nucleotide level between them in the S 
protein region segment 601-640, including the D614 
position [17]. Mutations of the viral genome have resulted 
in the emergence of distinct clades, whose variation may 
influence global disparities in infection rates. The initial 
outbreak in Wuhan was of Clade O, but the current 
dominant strain is thought to be the A2a variant. Unique 
mutations have been noted in studies conducted in several 
countries [18]. In terms of mutations in the A2a variant 
clade, a defining difference was observed in SARS-CoV-
2 S protein aspartic acid D614 resulting in a shift to 
glycine, creating a D614G mutation [17]. Other mutations 
have also been noted to contribute to SARS-CoV-2 global 
diversity. For example, the P323L mutation of RNA-
dependent RNA polymerase is hypothesized to be 
conserved during viral replication [18]. 
 
Figure 1. Global mortality and sexual disparity of COVID-19 by continents. (A) Global COVID-19 cases by sex 
and continent (B) Pie chart representation of the percentage of COVID-19 cases by sex. (C) Global mortality rate of 
COVID-19 deaths by sex and continent. (D) Pie chart representation of COVID-19 death percentages by sex. Male data 
is represented in blue, while female data is represented by pink. Overall, data suggests that males have an increased risk 
for COVID-19 infection and death, when compared to female counterparts. Data was generated from Global Health 
5050.org, on the 16th of November 2020.  
Human infection with SARS-CoV-2 is asymptomatic 
in many that are infected, aiding its ability to circulate 
undetected. In patients with severe disease acuity, the 
most common complications include pneumonia, 
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respiratory failure, sepsis, cardiac injury, arrhythmia, 
kidney injury, metabolic acidosis, or hypoxic 
encephalopathy [19]. These complications can worsen the 
symptoms of COVID-19 and might also be the reason for 
high death rates in older adults. 
 
3. COVID-19 global mortality rate and sex disparity 
 
From the infancy of the COVID-19 pandemic, researchers 
worldwide observed a disparity of morbidity and 
mortality between men and women. Data suggest that men 
who contract the virus tend to have more severe symptoms 
compared to women, potentially inflating their death rate. 
This may be explained by differences in sex steroid levels 
which can alter the immune response, thus leading to a 
disparity in disease burden [13]. Although infection rates 
amongst men and women are marginal, men have a higher 
death rate than women by 18.3%, with men accounting for 
59.15% of total deaths (Fig. 1). One proposed explanation 
is smoking, which is a habit more prevalent in men than 
in women [20]. SARS-CoV-2 is spread through and 
primarily affects the respiratory system, putting those who 
smoke at higher risk for severe complications. Smoking 
could exacerbate underlying conditions that would 
worsen symptoms and prognosis of COVID-19. This risk 
factor adversely affects outcomes in men.  
Outbreaks of similar coronaviruses, SARS and 
MERS, provide a foundation from which researchers can 
reference. One SARS study that focused on the role of sex 
hormones on infection and mortality in mice 
demonstrated that male mice were highly susceptible to 
the infection despite being exposed to the same viral load. 
Male mice also experienced 90% mortality compared to 
20% in female mice [12]. Researchers then compared 
gonadectomized mice to their counterparts after infection. 
The gonadectomized males did not show any difference 
in mortality or morbidity rate, but gonadectomized 
females had a significant increase in deaths [12]. These 
results suggest that testosterone may not play a role in 
infection or death rates; however, estrogen can influence 
both infection rates and disease severity.  
The afore-mentioned researchers also studied the 
relationship of age on SARS mortality rates. They 
concluded that the young age group was most resistant to 
infection, and all mice in the oldest group died [12]. The 
CDC has published that the average age of patients who 
progressed to ARDS was 61 years old, and those who 
were spared were on average 49 years old [21].  
 
 
Figure 2. Sex-dependent effects on COVID-19 hospitalizations and ICU admission by select 
countries.  (A) COVID-19 related hospitalizations; and (B) ICU admissions, by sex. Men and 
women are depicted by blue and pink datapoints, respectively. These charts reveal the overall male 
preponderance in COVID-19 hospitalization and ICU admission, with Norway exhibiting the 
largest sex-dependent predilection. The selected countries were chosen because they have publicly 
available data for hospitalizations and ICU admissions. Data was generated from Global Health 
5050.org, on the 16th of November 2020.  
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4. COVID-19-related hospitalizations and ICU 
admissions by sex 
 
Hospitalization and ICU admission rates by sex have 
recently become available for 10 countries: Canada, 
Chile, Denmark, France, Israel, New Zealand, Norway, 
Scotland, Spain, USA (Fig. 2). In these countries, males 
account for more than half of hospitalizations and ICU 
admissions. The largest sex difference observed occurred 
in Norway, with 60% of males being hospitalized and 
74% of males in the ICU. This trend brings into 
perspective the sex disparity in how males and females 
respond to COVID-19. Further analysis of data set reveals 
that, though both sexes are susceptible to SARS-CoV-2 
infection in the geriatric population, males are more likely 
to be admitted to the ICU (Fig. 2B). 
 
5. Prevalence of COVID-19-related deaths in nursing 
homes 
 
Nursing homes are long-term care facilities that provide 
health care services to people who are not eligible for 
hospital admission but cannot be cared for at home. 
Between 2015 and 2016, American adults aged 65 years 
and older made up about 83.5% of the total nursing home 
patient population [22]. Infection in nursing home care 
facilities, especially among older adults, is a longstanding 
healthcare challenge. In the current COVID-19 infection 
pandemic, nursing homes have been severely hit with 
disproportionately higher rates of mortality than the 
general population (Fig. 3). 
 
 
Figure 3. Total number of deaths in nursing homes linked to COVID-19. The United States has the highest 
rates of COVID-19 deaths in general. Overall, New Zealand saw a much lower total number of cases but 
observed the highest mortality rate within nursing homes when comparing deaths in nursing homes to total 
COVID-19 deaths. This figure highlights the relationship of COVID-19 related deaths (y-axis) from hospitals 
(blue bar graphs) to that of nursing homes (yellow bar graphs). The grey circles represent the percentage of 
nursing home deaths to the overall mortality rates linked to COVID-19. Countries are defined alphabetically 
along the x-axis.  
As of October 21st, 2020, international data from 22 
countries reveal that 46-47%  of the total mortality rate 
among nursing home residents is attributable to COVID-
19 related deaths [23]. For this analysis, COVID-19 
related death was defined as follows: i) death of a person 
who tests positive, before or after death, ii) death of a 
person who was clinically or epidemiologically suspected 
to have COVID-19,  and iii) excess deaths when 
compared to the deaths that occurred in the same week for 
the previous year [23]. The countries with the highest 
number of home care residents’ COVID-19 deaths as a 
percentage of all COVID-19 deaths include Slovenia 
(81.2%), Canada (79.5%), and Australia (75.4%). Jordan 
and South Korea had less than 10% of COVID-related 
deaths in nursing homes [23].  
It is important to consider  that most of the nursing 
home residents affected by COVID-19 had common 
chronic underlying conditions including hypertension, 
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cardiac disease, renal disease, diabetes, obesity, and 
pulmonary disease [24]. In terms of preventive measures 
against COVID-19 in nursing homes, the WHO published 
an interim COVID-19 prevention and control guidance 
for long-term care facilities on the 21st of March 2020 
[25]. The main objective of the guideline is to prevent 
increases in new cases as well as horizontal spread of 
COVID-19 within and outside of nursing home facilities. 
Similarly, the CDC also developed a COVID-19 Infection 
Control Assessment and Response (ICAR) tool to help 
nursing homes and other long-term care facilities assess 
their infection prevention preparedness and quality 
improvement so that lapses identified can be specifically 
addressed [26]. 
 
6. Considerations for clinical and therapeutic use of 
sex steroid hormones 
 
The three major sex steroid hormones are estrogen, 
progesterone, and testosterone. The hypothalamus-
pituitary-gonadal (HPG) axis regulates the 
neuroendocrine feedback loop that facilitates 
steroidogenesis. These hormones are synthesized 
endogenously but their levels vary by sex and decrease 
with older age. Sex hormones play crucial regulatory roles 
in the process of human development and directly have an 
impact on human behavior, anatomy, and physiology. 
Testosterone is the dominant hormone in males and 
estrogen/progesterone are the dominant hormones in 
females. Both males and females go through a decrease in 
sex hormone production with age, but the rate at which 
the level of sex hormones decreases depends on the 
individual. As the female body undergoes menopause, the 
natural cessation of menses, the level of sex hormones in 
the body dramatically decreases compared to the male 
body, which tapers off slowly over time [27, 28]. Factors 
such as obesity and chronic liver disease can also affect 
the concentration of estrogen amongst individuals [28]. 
Exogenous HRT can replenish the low levels or loss 
of sex hormones in an individual. For example, HRT is 
common among post-menopausal women to mitigate 
symptoms of menopause, such as hot flashes, night 
sweats, mood swings, and vaginal atrophy [28]. Both 
males and females experience a weakening of bones, a 
condition known as osteoporosis, which can also be 
countered therapeutically using hormone replacement 
therapy [28, 29]. Testosterone replacement is often 
supplemented in men through a topical gel [27], but is also 
provided orally in pill form, or administered via 
intramuscular injection. Estrogen is administered to 
females as estradiol, a potent form of estrogen, which 
comes in different forms such as pills, patches, topical 
creams and suppositories [28]. Progesterone is usually 
taken as a pill alongside estrogen because it can reduce the 
risk of some cancers and is available in other formulations 
such as progestin IUD or progestin dermal implant [28]. 
Though sex steroids are useful for hormone-balance 
restoration in post-menopausal adult females and aged 
adult males, several groups of scientists have reported on 
additional interesting therapeutic benefits of sex steroid 
hormones including their roles in alleviating disease 
burden due to viral infections [10].  
HRT has been associated with therapeutic benefits in 
improving patient outcomes in osteoporosis, 
cardiovascular disease, muscle mass, physical strength, 
and viral infections [8]. Potential risk factors of estrogen 
replacement therapy are breast and endometrial cancer 
[30]. However, there is no increased risk of developing 
cancer until after 15-20 years on estrogen replacement 
therapy (ERT) [30]. Trials were performed to further 
understand the risk and to evaluate ways to prevent 
malignancy; scientists concluded that using estrogen 
concurrently with progesterone can prevent osteoporosis 
without the increased risk of endometrial cancer but may 
increase risk for ischemic heart disease [30]. Although 
progesterone alone can have a preventative effect against 
endometrial cancer, its use should be carefully monitored 
because long term use of progesterone has been linked 
with the development of breast cancer [31]. 
In summary, HRT can be beneficial for both male and 
female geriatric patients who experience a natural 
decrease in sex hormone production. Not only does HRT 
mitigate undesirable side effects of aging such as 
decreased sex drive, hot flashes, and fatigue, but it can 
also reduce the risk of bone fractures and cardiac events. 
The focus of this review, however, is to assess the use of 
HRT to decrease disease burden in the geriatric 
population from SARS-CoV-2 virus infection. Such 
clinical trials investigating the efficacy of HRT for SARS-
CoV-2 are short-term, thus cancer risk in women may be 
negligible if patients are being treated in the duration of a 
pandemic.  
 
7. HRT to modulate immune response against SARS-
CoV-2 infection 
 
The two layering of the immunologic defense 
mechanisms of the body are the innate and adaptive 
subsystems [32]. The innate immunity is the first line of 
defense against SARS-CoV-2 infection. The main cellular 
components of the innate immune system include 
dendritic cells, monocytes, macrophages, granulocytes, 
and natural killer T cells [32]. However, when the acute 
response of the innate immunity is incapable of 
neutralizing and eliminating the invading virus, the 
adaptive immune system is mobilized to assist in 
combating the viral infection. The adaptive immune 
system is slow but specific, consisting of B and T cells 
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[32, 33]. The adaptive immune system is known to 
respond to infections by using antigen receptor genes to 
recognize invading pathogenic antigens [32]. Researchers 
are investigating the crosstalk between sex hormones and 
the immune system regulation with the rationale that sex 
hormones can influence the immune system against 
SARS-CoV-2 infection. For example, elevated estrogen 
concentration and/or estrogen receptor alpha (ERα) 
activation have been shown to enhance type I and III 
interferon (IFN) synthesis, leading to a resultant decrease 
in virus titer [34]. 
After a viral infection, an increased number and 
activation of immune cells including lymphocytes, 
myeloid cells, neutrophil leukocytes, monocytes, alveolar 
macrophages, and dendritic cells are observed in 
circulation [34]. Clinical and biomedical studies have 
reported that sex hormones can influence the function of 
immune cells against viral infections through binding to 
specific receptors expressed in circulating macrophages, 
dendritic cells, lymphocytes, and in various lymphoid 
tissues [34-36]. Upon binding of hormones to the 
receptors on immune cells, a cascade of signaling 
pathways including c-Jun, NF-κB, and interferon 
regulatory factor (IRF) 1 are influenced, resulting in 
varying levels of cytokine and pro-inflammatory 
responses [34]. Activated ERα has been shown to inhibit 
NF-kB mediated inflammatory response and cytokine 
production through regulation of cells of the immune 
system including lymphocytes, macrophages, and 
neutrophils [37]. 
Cytokine storm and excessive inflammation are two 
major physiological events associated with SARS-CoV-2 
viral infection [38-40]. The cytokine storm is usually 
associated with an inflammatory response to viral 
infections, triggering an increase in pro-inflammatory 
cytokine levels [41]. At normal physiological levels, sex 
steroid hormones, especially estrogen, have been reported 
to possess an anti-inflammatory effect, but this effect was 
seen only in pre-menopausal women [42-44]. However, it 
has been reported that though post-menopausal women 
have higher levels of pro-inflammatory cytokines, such as 
interleukin (IL)-6 and IL-1 (major cytokines involved in 
SARS-CoV-2 inflammatory process), the use of estrogen-
associated hormone replacement therapy can decrease the 
levels of these cytokines to pre-menopausal levels [44]. 
Testosterone, the major male sex steroid hormone, have 
also been reported to efficiently downregulate 
inflammation through the increase of anti-inflammatory 
cytokines (IL-10) and the decrease of pro-inflammatory 
cytokines (IL-1β, IL-6, and TNF-α) [45, 46]. These 
studies suggest that sex hormones are viable candidates 
for consideration in the development of therapeutics 




Figure 4. COVID-19 related deaths by age and sex in the top nine most affected countries: (A) USA (B) Italy (C) Peru (D) 
Philippines (E) France (F) Mexico (G) Bangladesh (H) Australia (I) South Africa. In all cases, there is a trend confirming that 
older adults experienced the highest death tolls from COVID-19. Additionally, in all cases herein, male patients exhibited higher 
mortality rates. In an effort to represent the global COVID-19 incidence and death rates, in each continent, we selected the highest-
ranking country with publicly available data. It is worth noting that in Australia, France, and Italy, adults over the age of 80, 
especially males (B & E), were significantly more impacted when compared to additional age groups in the other countries. Male 
data is represented in blue, while female data is represented by pink. Data was generated from Global Health 5050.org, on the 16th 
of November 2020.  
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8. Effects of aging, sex, and associated changes in 
immune system components 
 
The delicate balance between the innate and adaptive 
immune systems in response to pathogenic infections can 
be altered as age increases [47]. Not only does aging 
promote the chronic activation of the innate immune 
system and facilitates the decline of adaptive immune 
functions, it also causes a natural decline in sex hormone 
production [48-50]. Therefore, it is expected that females 
and males would differ in their susceptibility and response 
to SARS-CoV-2 infection, potentially explaining the 
obvious disparity in incidence, severity, and mortality 
rate. The activity of innate immune cells like macrophages 
and dendritic cells inducing inflammatory responses are 
generally higher post viral infection in females than in 
males, as demonstrated in several animal studies [51-53]. 
It is therefore plausible to conclude that the nature of 
immune response to SARS-CoV-2 infection can be 
altered by supplementing endogenous sex steroid 
hormones at various physiological stages, such as before 
and after menopause, during pregnancy, and during 
hormone replacement therapy [54]. The changes in 
immune components have been observed to show a 
bimodal sex hormone decline by age distribution. The first 
time point occurs in both men and women around 40 years 
of age, and the second time point occurs in men around 
the early/mid 60’s and women around the late 60’s [47].  
In China, it was observed that there was a doubling in 
COVID-19 death rate in individuals around 40 years old 
from 0.2% to 0.4% (www.worldometers.info/ coronavirus 
/coronavirus-age-sex-demographics/). A second wave of 
declining immunity occurs in individuals around 60 years 
which coincides with an increase in severity and lethality 
of COVID-19. This pattern is evident in the death rates 
reported in different countries of the world (Fig. 4). 
Interestingly, Italy, France, and Australia (Fig. 4B, 4E, 
and 4H, respectively) have responded to the pandemic 
effectively enough that the population ages 40-60 years 
are well protected. This is evident from the lower age-
dependent incidence of COVID-19 cases. Worth noting, 
the mortality rate in males in Italy (Fig. 4B) and France 
(Fig. 4E) were significantly higher than males in other 
countries.  
A recent study of 244 older COVID-19 patients 
reported that age and decreased lymphocyte count were 
independently associated with hospital mortality [55]. 
Another recent study has shown evidence that the timing 
of age-related changes in the immune system differ 
between men and women [56]. The authors reported that 
aging-related changes in both men and women included a 
decline in adaptive immunity, and an activation of innate 
immunity. These changes of increased inflammatory 
events were reported to be more devastating in men. 
According to their data, peripheral blood B lymphocytes 
were lower in older men aged 65+ years. This result 
corresponds with clinical study data generated from 
separate cohorts in France [56] and Japan [57]. Therefore, 
these lines of evidence suggest that sex-related changes in 
immunity can be altered by sex and with increase in age.  
Presently, sex steroid hormones are among the list of 
potential therapies being considered for preventing and 
improving symptoms of COVID-19 disease. However, 
there is currently no published study evaluating the effect 
of HRT intervention for the different stages of COVID-19 
in patients [58]. Hence, more biomedical and clinical 
translational studies are needed to better understand the 
pharmacological effects of exogenous hormone 
replacement dosing and duration that can alleviate 
COVID-19 incidence in patients. 
 
9. Sex hormone therapy to prevent COVID-19 
infection in the geriatric population 
 
There is still a paucity of therapeutic options for treating 
COVID-19. Additionally, there are insufficient number of 
testing sites in many countries around the world, 
particularly in underdeveloped countries. Currently, 
physicians may only offer supportive care to patients who 
have severe symptoms and require hospitalization. In the 
most severe cases, remdesivir, a nucleoside analog, may 
be administered to patients [59]. Remdesivir is an antiviral 
drug that functions to inhibit the viral genome replication 
of SARS-CoV-2 [60]. While we are optimistic that 
remdesivir will have minimal long-term side effects, we 
also believe that exploring other potential alternatives for 
COVID-19 treatment would be in the best interest of the 
citizens of the world. We now know that sex hormones 
have other biological functions including antiviral effects. 
Therefore, it is rational to consider sex steroid hormones 
as potential treatment option in alleviating COVID-19 
inflammatory and cytokine storm events, thereby 
improving quality of life for geriatric individuals, 
especially male counterparts.  
 
9.1. Androgen (Testosterone) 
 
It has been reported that androgen receptor activity is a 
requirement for the transcription of the transmembrane 
protease, serine 2 (TMPRSS2) gene [46, 61, 62], a cell 
surface protein that is expressed by epithelial cells of 
specific tissues including those in the aerodigestive tract 
[61]. Also, there is existing evidence that TMPRSS2 
activity is necessary for the activation of the SARS-CoV-
2 spike protein, viral entry, and spread in an infected host 
[61, 62]. Of note, SARS-CoV, the virus responsible for 
the 2003 SARS outbreak, H1N1 influenza, and the virus 
responsible for the 1918 and 2009 influenza pandemics, 
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depend on TMPRSS2 for viral activation and cell entry 
[63-65]. These studies have a unifying conclusion that the 
upregulation of TMPRSS2 by androgen receptor activity 
could be the reason for the increased male predominance 
in deaths from COVID-19. Surprisingly, we have come to 
realize that this is not the universally accepted belief in the 
research field, many researchers maintain differing 
opinions.  
A recent report has evidence that testosterone 
supplementation can reduce COVID-19 cytokine storm 
effect; thereby, suppressing SARS-CoV-2 induced 
inflammation [46]. In SARS-CoV-2 pneumonia patients, 
lower total testosterone (TT) was found in patients 
transferred to the ICU or deceased in the respiratory 
intensive care units (RICU) compared to patients 
transferred to internal medicine units or maintained in the 
RICU in stable condition [62]. Another group conducted 
a retrospective study where the investigators 
systematically analyzed sex hormones as well as cytokine 
and chemokine responses in male and female patients 
with laboratory-confirmed SARS-CoV-2 infections. They 
reported that a significant number of male COVID-19 
patients had low testosterone (68.6%) and low 
dihydrotestosterone (48.6%) levels [66]. Though these 
studies were conducted in SARS-CoV-2 infected patients, 
we still believe that more studies are needed to validate 
the antiviral effect of testosterone. Presently, there are on-
going COVID-19 clinical trials experimenting with 
progesterone and estrogen but there is yet to be a clinical 





Compared to estrogen and testosterone, there are fewer 
studies investigating the therapeutic potential of 
progesterone in reducing the disease burden of COVID-
19 patients, particularly in older adults. Progesterone 
deserves more research for its possible antiviral effect 
against SARS-CoV-2 as there is existing evidence that 
progesterone has antiviral effects against HIV [67] and 
against influenza virus A [63]. Progesterone has also been 
reported to reduce inflammatory events at mucosal sites, 
like the respiratory tracts post-viral infection [68]. In 
2010, a study reported that there was an observable 
decrease in progesterone levels in SARS patients 
compared to healthy controls. This implies that 
progesterone signaling pathway might be involved in 
antiviral immune response. 
More recently, a study published in Nature reports 
that progesterone has an anti-SARS-CoV-2 effect [69]. 
Another group reported that, in their study, four out of 
eight pregnant women infected with SARS-CoV-2 were 
asymptomatic before delivery but became symptomatic 
post-partum [70] further suggesting that progesterone 
could be protective against SARS-CoV-2 infection. This 
finding further strengthens the case that progesterone, 
which is elevated during pregnancy and abruptly drops 
upon delivery, might have potent anti-viral properties. 
Furthermore, another recent study has also reported that 
progesterone, in addition to estrogen and testosterone, has 
anti-SARS-CoV-2 effect notably in older adults [71]. 
Presently, there is an ongoing clinical trial 
[NCT04365127] that seeks to investigate the safety and 
efficacy of progesterone for treatment of COVID-19 in 
hospitalized men (Table 1). The findings from this clinical 
trial will strengthen or weaken the existing evidence that 
progesterone has antiviral activity against SARS-CoV-2. 
9.3. Estrogen 
Estrogen is the most studied sex steroid hormone because 
of its many therapeutic uses, especially in combating viral 
infections. Estrogen (17β-estradiol) has been reported to 
have antiviral effects against viruses including influenza 
virus [72], hepatitis C virus [73], SARS [74], and SARS-
CoV-2 [13, 71]. Estrogen and its immunomodulating 
effects against SARS-CoV-2 infection is presently under 
active investigation in different laboratories around the 
world. Very recently, estrogen was shown to possess anti-
SARS-CoV-2 effect which occurs through the 
suppression of TMPRSS2 expression in different cell 
lines [13]. The antiviral effect of estrogen is due, in part, 
to the many antiviral genes or inflammatory genes that 
have estrogen response elements (EREs) in their promoter 
regions which enhances estrogen-mediated cellular 
signaling [13].  
In 2013, Hilliard et al. reported that estrogen-
induced expression of ACE-2 is reduced in 
postmenopausal women [75]. This study, again, brings to 
the forefront a relevant clue why elderly women are likely 
less susceptible to SARS-CoV-2 infection than elderly 
men. According to Suba et al, Premarin, can have gene 
repairing power like endogenous estrogen without risk of 
adverse reactions [14]. Premarin is a conjugated equine 
estrogen derived from natural sources and has been 
reported to have proven antiviral efficacy [14]. Presently, 
there is an ongoing clinical trial [NCT04359329] that 
seeks to investigate if estrogen, given as a patch placed on 
the skin of COVID-19 patients including older adults can 
reduce the severity of COVID-19 symptoms compared to 
regular care (Table 1). Again, the findings from this 
clinical trial will strengthen or weaken the existing 
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The global burden of COVID-19 is taking a toll on 
financial, economic, and healthcare sectors of many 
countries around the world. This comprehensive review 
seeks to report, using a biomedical and clinical knowledge 
base, on one of the controversial topics that is worth 
further investigation at this critical time. Sex hormones 
are produced endogenously; therefore, they are not 
harmful to the body or possess adverse effects if their 
normal levels are maintained. However, the signaling 
pathways or events related to gene transcription might be 
altered leading to modified levels of these hormones 
which might then pose some physiological consequences. 
Here, we have summarized the perspectives of several 
endocrine, aging, and immunology scientists on the 
subject matter of sex hormones and how they regulate 
immune function against SARS-CoV-2 infection.  
Here we have gathered and analyzed data sets that are 
available to the public to investigate the prevalence of 
COVID-19 related cases and deaths by continents. We 
then repeated the same process for COVID-19 related 
hospitalizations and ICU admissions in top countries with 
high COVID-19 prevalence. Finally, we analyzed death 
rates by sex and age to further strengthen our hypothesis 
that men are globally more affected by COVID-19 
infection than women. Herein, we have summarized the 
main highlights and conclusions of relevant scientific and 
clinical studies published on sex hormone functions in 
immunity, aging, and against SARS-CoV-2 infection. 
There are now multiple sources of evidence that show 
how sex hormones can be used as viable candidates for 
consideration as potential antiviral prophylaxis. However, 
it should be noted that HRT could have some side effects 
such as breast and endometrial cancer in women. 
In conclusion, compared to women, men are at higher 
risk of SARS-CoV-2 infection, ICU admission, 
hospitalization, and death rate in countries around the 
world. This disparity in COVID-19 pandemic is most 
likely multifaceted (biological, lifestyle, and 
comorbidities, etc.) but sex hormone levels are arguably 
one of the primary reasons why men and women respond 
differently to SARS-CoV-2 infection. As the virus 
continues to evolve and spread, there is an urgent need for 
more treatment options and therapeutic modalities that 
will be aimed at neutralizing SARS-CoV-2 infection and 
improving symptoms of the COVID-19 disease. 
Therefore, we recommend that the use of sex hormone as 
possible therapy for COVID-19 older adults be given 
maximum consideration as this clinical intervention might 
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